Last reviewed · How we verify

NCT03951792

Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects

Completed Last updated 18 April 2024
What this trial tests

trial in Cancer Colon in 220 participants. Completed in 15 March 2024.

Timeline
28 May 2019
Primary endpoint
15 March 2024
15 March 2024

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment220
Start date28 May 2019
Primary completion15 March 2024
Estimated completion15 March 2024
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Cancer Colon or Gastrointestinal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Current status and perspectives of genetic testing in gastrointestinal cancer (Review).
    Matsuoka T, Yashiro M. · · 2024 · cited 4× · PMID 38058469 · DOI 10.3892/ol.2023.14155

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing